Get the Stockscreener App
193.04
0.00%
0.00
After Hours:
193.04
Overview
News
Price History
Option Chain
Financials
Why BDX Down?
Discussions
Forecast
Stock Split
Dividend History
Becton Dickinson Co stock is traded at $193.04, with a volume of 3.35M.
It is up +0.00% in the last 24 hours and up +2.48% over the past month.
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of 2024 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.
See More
Previous Close:
$193.04
Open:
$193.04
24h Volume:
3.35M
Relative Volume:
1.72
Market Cap:
$55.33B
Revenue:
$21.84B
Net Income/Loss:
$1.68B
P/E Ratio:
33.10
EPS:
5.8322
Net Cash Flow:
$2.67B
1W Performance:
+8.55%
1M Performance:
+2.48%
6M Performance:
+12.88%
1Y Performance:
-15.02%
1-Day Range:
$191.76
$194.50
1-Week Range:
$175.93
$195.74
52-Week Range:
$162.29
$251.99
Becton Dickinson Co Stock (BDX) Company Profile
Name
Becton Dickinson Co
Sector
Industry
Phone
(201) 847-6800
Address
ONE BECTON DR, FRANKLIN LAKES
Compare BDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
193.04 | 55.33B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ISRG
Intuitive Surgical Inc
|
549.51 | 200.47B | 9.61B | 2.77B | 2.27B | 7.555 |
|
ALC
Alcon Inc
|
77.65 | 38.61B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
244.46 | 36.80B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
261.36 | 19.18B | 2.96B | 487.70M | 344.00M | 6.6758 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-25-25 | Initiated | RBC Capital Mkts | Sector Perform |
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| May-02-25 | Downgrade | Goldman | Buy → Neutral |
| May-02-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-02-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-01-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-01-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Jul-24-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| May-05-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-12-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-03-23 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-12-22 | Upgrade | Citigroup | Sell → Neutral |
| Jul-11-22 | Downgrade | Citigroup | Neutral → Sell |
| Jun-24-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-22 | Resumed | Raymond James | Mkt Perform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-08-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-09-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-01-20 | Resumed | Goldman | Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-07-20 | Downgrade | Cowen | Outperform → Market Perform |
| Feb-07-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-07-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Feb-06-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-08-20 | Downgrade | Barclays | Overweight → Equal Weight |
| May-13-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-07-18 | Initiated | Deutsche Bank | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Jun-21-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-10-18 | Upgrade | Citigroup | Neutral → Buy |
| Jan-19-18 | Resumed | BofA/Merrill | Buy |
| Jan-05-18 | Upgrade | Citigroup | Sell → Neutral |
| Jan-05-18 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Dec-29-17 | Reiterated | Deutsche Bank | Buy |
View All
Becton Dickinson Co Stock (BDX) Latest News
Is Becton Dickinson and Company stock bottoming out2025 EndofYear Setup & Verified Trade Idea Suggestions - newser.com
Will Becton Dickinson and Company rebound enough to break evenEarnings Recap Summary & AI Driven Stock Price Forecasts - newser.com
Can you recover from losses in Becton Dickinson and CompanyJuly 2025 Gainers & Technical Entry and Exit Tips - newser.com
GalaFLEX Breast Mesh Problems Were Highlighted in Warnings Issued by Former Becton Dickinson Medical Director - AboutLawsuits.com
First Pacific Advisors' Strategic Moves: Becton Dickinson & Co Takes Center Stage - GuruFocus
How forex fluctuations impact Becton Dickinson and Company (BOX) stockTrade Exit Report & Verified Short-Term Trading Plans - newser.com
Duncan Regional Hospital Becomes First in U.S. to Implement BD Alaris EMR Infusion Interoperability with MEDITECH - Finviz
What Are Wall Street Analysts' Target Price for Becton, Dickinson and Company Stock? - inkl
Duncan Regional Hospital Becomes First in U.S. to Implement BD Alaris™ EMR Infusion Interoperability with MEDITECH - MarketScreener
BD (NYSE: BDX) adds MEDITECH to Alaris EMR interoperability; 960+ sites live - Stock Titan
Is a relief rally coming for Becton Dickinson and Company holdersMarket Sentiment Summary & Weekly Momentum Stock Picks - newser.com
Becton, Dickinson and Company Introduces PureWick Portable Collection System - MarketScreener
BD Expands PureWick™ Portfolio with First-of-its-Kind Portable Solution to Confidently Manage Urinary Incontinence On the Go - MarketScreener
BD (NYSE: BDX) Launches PureWick Portable for Wheelchairs, 8-Hour Battery Urine System - Stock Titan
Is Becton Dickinson and Company building a consolidation baseGap Down & Stock Timing and Entry Methods - newser.com
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
Becton, Dickinson & Co. Experiences Valuation Adjustment Amidst Competitive Market Landscape - Markets Mojo
Real time alert setup for Becton Dickinson and Company performanceQuarterly Trade Report & Precise Trade Entry Recommendations - newser.com
Got $1,000? Here Are the Smartest Dividend Stocks to Start With. - The Motley Fool
Becton Dickinson (NYSE:BDX) Is Increasing Its Dividend To $1.05 - Yahoo Finance
Becton Dickinson director Scott sells $38,317 in stock By Investing.com - Investing.com South Africa
Becton Dickinson price target lowered to $202 from $211 at RBC Capital - MSN
Becton, Dickinson & Co. Hits New 52-Week Low at $162.50 - Markets Mojo
Becton, Dickinson and Company (NYSE:BDX) Q4 2025 Earnings Call Transcript - Insider Monkey
Becton Dickinson price target lowered to $190 from $200 at Piper Sandler - TipRanks
Director’s Stock Sale: Discover the Latest Becton Dickinson Transaction - TipRanks
Becton Dickinson price target lowered to $210 from $224 at Stifel - MSN
Insider Sell: Bertram Scott Sells Shares of Becton Dickinson & C - GuruFocus
RBC Capital Maintains Becton, Dickinson and (BDX) Sector Perform Recommendation - Nasdaq
Becton Dickinson director Scott sells $38,317 in stock - Investing.com India
BECTON DICKINSON Director Sells Shares - TradingView
Piper Sandler Adjusts Becton, Dickinson and Company Price Target to $190 From $200 - MarketScreener
Stifel Nicolaus Adjusts Becton, Dickinson and Company Price Target to $210 From $224 - MarketScreener
Jefferies & Co Adjusts Becton, Dickinson and Company Price Target to $215 From $257 - MarketScreener
Becton, Dickinson and Co Reports Strong Fiscal 2025 Results - MSN
Stifel Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Cuts Target Price to $210 - 富途牛牛
BofA Securities Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $190 - 富途牛牛
RBC Capital Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Cuts Target Price to $202 - 富途牛牛
Becton Dickinson stock hits 52-week low at 162.3 USD By Investing.com - Investing.com Australia
Becton Dickinson: Fiscal Q4 Earnings Snapshot - CT Insider
Becton, Dickinson And Company: Strong Earnings But Murky Outlook (NYSE:BDX) - Seeking Alpha
Becton Dickinson & Co To Go Ex-Dividend On December 8th, 2025 With 1.05 USD Dividend Per Share - 富途牛牛
Becton, Dickinson (BDX) Reports Strong Q4 and Sets Optimistic 20 - GuruFocus
Becton Dickinson & Co (BDX) Q4 2025 Earnings Call Highlights: St - GuruFocus
Becton Dickinson & Co (BDX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Becton, Dickinson and Company (BDX) Stock Forecasts - Yahoo Finance
Will Becton Dickinson and Company stock profit from fiscal stimulus2025 Trade Ideas & Reliable Intraday Trade Plans - newser.com
TD Cowen Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $183 - 富途牛牛
Becton Dickinson Sees High Single-Digit Profit Growth Ahead, Plans Share Buybacks From Waters Deal - Benzinga
Becton Dickinson Co Stock (BDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.22%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):